Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders

MeSH terms

• Age Factors
• Antibiotic Prophylaxis / methods
• Antiviral Agents / administration & dosage*
• Antiviral Agents / pharmacokinetics
• Betacoronavirus / immunology*
• COVID-19
• COVID-19 Drug Treatment
• Clinical Trials as Topic
• Coronavirus Infections / drug therapy
• Coronavirus Infections / epidemiology
• Coronavirus Infections / immunology
• Coronavirus Infections / prevention & control
• Coronavirus Infections / therapy*
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Drugs, Investigational / administration & dosage*
• Drugs, Investigational / pharmacokinetics
• Humans
• Immunocompromised Host
• Infectious Disease Transmission, Patient-to-Professional / prevention & control
• Pandemics / prevention & control
• Pneumonia, Viral / epidemiology
• Pneumonia, Viral / immunology
• Pneumonia, Viral / prevention & control
• Pneumonia, Viral / therapy*
• SARS-CoV-2